Volume 23 (2020)
Volume 22 (2019)
Volume 21 (2018)
Volume 20 (2017)
Volume 19 (2016)
Volume 18 (2015)
Volume 17 (2014)
Volume 16 (2013)
Volume 15 (2012)
Volume 14 (2011)
Volume 13 (2010)
Volume 12 (2009)
Volume 11 (2008)
Volume 10 (2007)
Volume 9 (2006)
Volume 8 (2005)
Volume 7 (2004)
Volume 6 (2002)
Volume 5 (2002)
Volume 4 (2000)
Volume 3 (1999)
Volume 2 (1998)
Volume 1 (1997)
1. The efficacy of topical treatment with concentrated boiled extract and Hydroalcoholic extract of cassia fistula in comparison with intralesional injection of Glucantime in the treatment of acute Leishmaniasis

F Jafari; Sh Moradi; MA Nilforoush Zadeh; R Derakhshan; N Ansari

Volume 9, Issue 3 , 2006, , Pages 211-216

Abstract
  Background and aim: Cutaneous leishmaniasis is an endemic disease in Iran. Although there are many different treatments for this disease, there is not any effective treatment yet. Since there has been a number of different reports on the effectiveness of Cassia fistula plant in the treatment of leishmaniasis, ...  Read More

2. Efficacy of combination of topical honey with intralesional injection of Gglucantime in the treatment of acute cutaneous Leishmaniasis

MA Nilforoush Zadeh; Sh Moradi; R Derakhshan; E Haft Baradaran; F Jafari

Volume 9, Issue 3 , 2006, , Pages 221-226

Abstract
  Background and aim: Cutaneous leishmaniasis (CL) is an edemic disease widely spread in Iran. Although several treatments have been tried, none has been found as simple and effective. Honey has been used in the treatment of chronic ulcers and its anti-leishmanial effects have also been reported. So we ...  Read More

4. Frequency of resistance to systemically administered Meglumine Antimoniate (Glucantime) in patients with acute cutaneous Leishmaniasis: A cross-sectional study

MA Nilfroush Zadeh; N Anasri; R Derakhshan

Volume 8, Issue 6 , 2006, , Pages 457-461

Abstract
  Background and aim: Pentavalent antimony compounds are the first line treatment for cutaneous leishmaniasis. Clinical resistance to pentavalent antimony in the form of meglumine antimoniate (Glucantime) has been recognized as a problem in leishmaniasis. Herein, clinical response to Glucantime were studied ...  Read More